Skip to main content

What We Do
Who We Serve
About Omada
Search
View Demo
Contact Us

Omada Health

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Latest Content
A1C reduction drives whole health outcomes

A1C reduction drives whole health outcomes

Published Date March 23, 2022

Author Omada Health

Omada Health Launches
GLP-1-Specific Program

Learn More

Previous Article

Customer Q&A Blog: St Louis County

Located in northeastern Minnesota, St Louis County is the largest U.S. county east of the Mississippi spread across over 7,000 square miles. Representing a mix of urban and rural...
Next Article

3 Ways Healthcare Gets Behavioral Change Wrong

An integral component of changing health outcomes is changing behaviors. How does the current slate of virtual health options out there address behavior change when it comes to treating...

Other content in this Stream

Omada Health Publishes Findings from Consumer Survey of GLP-1 Users

Survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals; respondents want to lose an average of 22% more weight.

Read Article
17 days ago
GLP-1 Discontinuation: Real-World Perspectives on a Complex Journey

Omada Insights Lab surveyed and interviewed Omada members with a history of GLP-1 use to learn more about their unique needs and experiences.

Read Resource
17 days ago
The 28 Billion Dollar Reason Heart Health Matters in Women Post-menopause

Cardiovascular disease (CVD) remains the leading cause of death among women, yet it is often misdiagnosed and/or undertreated. Join the discussion on the need for more focus on women's heart health.

Watch Video
21 days ago
The GLP-1 Journey

New consumer data indicates that sustaining weight loss and overall well-being requires intervention beyond the GLP-1

Read Resource
21 days ago
Whole-Person Well-Being Over Profits

Return on Health Framework for Realizing the Value of Virtual Care

Read Resource
Anne Beal, MD, MPH Joins Omada Health Board of Directors

Dr. Beal brings extensive experience in clinical innovation, patient advocacy, and population health to Omada’s Board.

Read Article
2 months ago
How Social Support Influences Weight Health for GLP-1 Users

As the healthcare industry innovates to maximize the GLP-1 experience for patients, there appears to be an important factor that’s arguably under-discussed: loneliness.

Read Article
3 months ago
The Problem with BMI: Addressing Inequities in Obesity Screening

With its checkered past and at times questioned clinical merits, BMI’s ubiquity in modern healthcare should be carefully considered.

Read Resource
3 months ago
3 Reasons GLP-1 Care Must Consider the Entire MSK System, Not Just Muscle Mass

Most people know that GLP-1 care can impact muscle mass, but it's important to consider the entire MSK system. Find out 3 reasons why with Omada Health.

Read Article
3 months ago
New GLP-1 Indications: What you need to know

This insightful webinar delves into the expanding role of GLP-1 medications in treating a wide range of chronic conditions beyond diabetes and obesity.

Watch Video
Omada Health adds Sachin Jain, M.D., MBA, Julie Klapstein and Adam Stavisky to Board of Directors

New board members provide deep clinical and commercial experience.

Read Article
4 months ago
Omada Health’s Guide to GLP-1s | Q3 - Q4 2024

Omada drills into emerging details of the GLP-1 experience, including compounded GLP-1s, how to manage the drug’s impact on body composition, & ways to assess the value of virtual companion programs.

Read Article
5 months ago
Using AI to Strengthen Human Relationships: Q&A with Terry Miller, VP of Machine Learning, AI and Data Science Strategy

Q&A with Terry Miller, VP of Machine Learning, AI and Data Science Strategy

Read Article
5 months ago
Economic Savings Model for Omada’s Cardiometabolic Programs

Economic Savings Model for Omada’s Cardiometabolic Programs

Read Article
5 months ago
Omada Joins Pledge to White House-Supported Healthcare AI Commitments

Company pledges to keep humans at the center of care.

Read Article
5 months ago
Omada Health's Journey with Artificial Intelligence

How Data Science and AI learnings surprised us, taught us, and propelled us forward.

Read Article
6 months ago
AHIP 2024

Omada Health: Shining as a Gold Level Sponsor at AHIP 2024!

Read Article
8 months ago
Life With GLP-1s

Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry.

Read Resource
8 months ago
New Research Shows Long-Term A1C Reduction and Sustained Weight Maintenance for Members in Omada Health’s Type 2 Diabetes Program

Omada Health, the virtual-first healthcare provider, published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes

Read Article
8 months ago
New Data Published by Omada Health Demonstrates the Impact of Coupling GLP-1s and Behavior Change Programming

Findings show that meaningfully engaged Omada members on GLP-1s achieved an average of 1.7 times greater weight loss, and inform a new collaboration with Evernorth's EncircleRx program.

Read Article

Return to Home

Become an Omada Insider

Subscribe

Why Omada?
Who We Serve

The Omada Platform
- PROGRAMS
Insights Lab

For Individuals
- CONDITIONS WE TREAT
- SUPPORT
  - Help Center
  - FAQs

Resource Center

About Omada
- About
- Leadership
- Customers
- Careers
- Press
- Security
- Contact Us

Privacy Policy
HIPAA
Terms of Use
Member Rights & Responsibilities

Omada Health, Inc. works in partnership with Physera Physical Therapy Group, PC and other contracted partners to be your Omada care team and deliver certain clinical services as part of the Omada programs.

The Omada Platform

PROGRAMS

Insights Lab

WHO WE SERVE

About Omada

Become an Omada Insider